Key facts
| Price (PPV) | 94.70 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | candésartanhydrochlorothiazide |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09DA06 |
| Manufacturer | SYNTHEMEDIC |
| Presentation | Boîte de 28 |
| Nature | Médicament |
| Hospital price | 59.20 MAD |
| Data collected on | 9/8/2026 |
Indications
traitement de l'hypertension essentielle, lorsqu'une monothérapie ne permet d'obtenir qu'un effet insuffisant.
Find an open pharmacy
On-call pharmacies near you
About Hytacand 8 mg / 12.5 mg
Hytacand 8 mg / 12.5 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by SYNTHEMEDIC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Hytacand 8 mg / 12.5 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Hytacand 8 mg / 12.5 mg
Answers to common questions from Moroccan patients about this drug.